Advisory Board Member
Paul Sargeant has served as Chief Executive Officer of Rebus Biosystems since 2020 bringing more than 25 years of strategy, commercial, product development, fundraising and execution successes in the life sciences, medical device and clinical diagnostic sectors. Prior to joining Rebus Biosystems he was CEO of Clearbridge Biophotonics, a computational imaging division of Clearbridge Health (Singapore), where he also served as COO. Paul also served as a senior executive with startups and Fortune 100 companies including Medtronic and ThermoScientific and ran his own consulting company, Lucidity Inc. working with defense & security players and global health organizations working in Africa and SE Asia. Paul earned a PhD in Physiology from University of Cambridge, UK.